BACKGROUND: Chronic hepatitis C (HCV) infection affects millions of people in the USA and prevalence rates are higher in US veterans. The consequences of HCV infection include reduced quality of life, liver damage, and reduced longevity.
INTRODUCTION
Chronic hepatitis C (HCV) infection affects about 1.8% of the general US population [1] [2] [3] and an estimated 5.4% of VA patients 4 or three times the general population rate. Chronic HCV infection leads to severe medical consequences in about 30% of cases 5 and is the leading reason for liver transplantation in the US. Overall, societal costs are projected to be as high as $50 billion over the next decade 6 . In HCV-infected individuals not experiencing severe consequences, healthrelated quality of life is often impacted [7] [8] [9] [10] [11] 12 . Symptoms include fatigue, abdominal pain, nausea, weight loss, and functional limitations. Anxiety and depression can emerge after being diagnosed with HCV, or from living with a serious, potentially lethal chronic disease 9, 10 .
Antiviral treatment eliminates the virus in approximately 45% of patients [13] [14] [15] , but most VA patients never receive treatment 16 , because they are either ineligible or refuse treatment. Recommendations for HCV patients who are not current candidates for antiviral treatment include adhering to follow-up appointments and following self-care guidelines 17, 18 . Unfortunately, many HCV patients have difficulty following these recommendations without additional assistance or intervention 19 . Self-management programs are one option for helping HCV-infected patients adhere to treatment recommendations. Self-management programs provide problem-solving and behavioral skills along with disease-specific information. They have been shown to improve chronic symptoms, increase health-supporting behaviors, and enhance overall quality of life [20] [21] [22] while consuming few medical care resources 23, 24 with other chronic diseases.
Despite the need for such approaches, relevant empirical data are limited. Our primary objective was to describe the experiences and challenges faced by VA patients living with HCV and inform the development of an HCV self-management program. These qualitative data provide the patient's perspective and were combined with input from HCV clinicians, researchers, and behavioral scientists in developing the HCV self-management program.
Patients' Views of Hepatitis C
Our approach was to use qualitative methods to gain insight into the experiences of HCV-infected patients, an approach that has proved informative in helping patients manage similarly challenging chronic illnesses, such as HIV 25 . Qualitative methods have been used before to describe the experi-ences of people living with HCV, but have not focused on US veterans. Results suggest that being diagnosed with HCV produces distress; the disease carries an ominous prognosis and negative images are associated with contagious disease and stigmatized risk factor behavior 10, 26 . Patients may suddenly feel unclean regardless of their previous lifestyle, and find their new illness framed by shame and discrimination.
Living with HCV often entails significant physical, cognitive and emotional adjustments as well. Debilitating symptoms and the medications used to treat HCV may impair daily activities, social roles, and work performance 26, 30 . For example, fatigue is common to HCV-infected individuals and interferes with many daily activities, however, the severity of fatigue varies widely among individuals 27 . Social support is critical for adjustment, but its receipt is complicated. Relationships may be strained by worries about sufferers' uncertain health; partners, family, and friends may withdraw out of fear of infection or distaste, and physical and cognitive impairments may limit social interaction 28 . Healthcare professionals play a major role in providing supportive guidance for HCV-infected patients yet patients have also reported significant strains in these important relationships 26 . Zickmund and her coworkers have found that conflict and communication problems were not uncommon in HCV patients' accounts of their clinical care 29, 30 .
Since IV drug use is the leading cause of new HCV infections 31 , qualitative researchers have focused on topics such as prevention 32, 33 , the diagnosis experience 34 , and the experience of living with HCV among IV drug users 35 . Results
suggest that knowledge about the risk of HCV infection was fairly good but needle sharing and risky behaviors still occurred when safer options appeared limited. Despite knowledge of the risks, homeless IV drug users were often shocked and angry after receiving a positive diagnosis 34 and these negative feelings persisted for years. Finally, the experience of antiviral treatment for HCV has also been studied qualitatively 36, 37 . These studies used participant narratives to describe the side effects of antiviral treatment and associated emotional reactions. 
METHODS

Participants
Procedure
Semi-structured interviews were conducted by two researchers with experience conducting clinical health assessments. Questions were designed to focus on three broad areas: medical history, experiences of contracting and being diagnosed with HCV, and the ways in which HCV affected their lives. The respondents were encouraged to expand on these issues and redirect the conversation if they desired. The interviews averaged about 40 minutes in length and were audiotaped, transcribed, and de-identified for analysis. The interviewers made detailed notes and summarized each interview shortly after it occurred. Interviews were conducted in English.
Assessment Instrument
The semi-structure qualitative interview consisted of 11 questions (see Appendix A). The theoretical construct of healthrelated quality of life was used to guide the development of the interview questions [38] [39] [40] . The questions were also influenced by two secondary sources: a) input from clinicians at a VA Hepatitis C Clinic; and b) domains covered by published qualitative studies of HCV-infected individuals.
Data Analysis
Means and proportions were obtained for the sociodemographic and available clinical characteristics of participants. Interview transcripts and notes were independently reviewed and coded by two researchers. Prior to beginning coding, the researchers underwent training on the theoretical concepts of health-related quality of life. They also reviewed existing qualitative literature on HCV infection and conferred with clinicians from the local VA HCV clinic. For the analysis, interview texts were first examined and each sentence or idea was classified into topics. Next, broader themes were independently identified by each reviewer and the two lists of themes were compared and discussed by the two reviewers. When discrepancies among themes arose, the researchers referred to the theoretical principles of health-related quality of life. Each reviewer's reasons for creating and labeling the themes were discussed and data were re-reviewed until a common theme label was agreed upon or a new theme was created. Discrepancies centered around the number of themes created. For example, one reviewer created a theme for emotions such as fear, anger, and guilt. After discussion, the emotions were subsumed under existing themes/contexts to which the emotions were linked (diagnosis, relationship, treatment) In addition, a new theme was created for contracting HCV because one reviewer noticed differences in internal versus external attributions of control.
RESULTS
Participant demographics are described in Table 1 .
The themes that were agreed upon by the reviewers are summarized in Table 2 . Participant quotes and narratives are presented below and correspond to the themes that were identified.
Theme 1 -Reaction to Diagnosis
The mean self-reported amount of time since first diagnosis was 7.3 years (sd=6.9). Initial reactions to the diagnosis of HCV included fear, denial, and/or shame. Other reactions mentioned were relief, guilt, anger, depression, hopelessness, and worry about death. One participant described his reaction as: "I was a little depressed knowing there's no actual cure … I hear it's not a great process to go through. There's depression and suicidal tendencies." Another participant reported that when he received the diagnosis, he thought HCV was like HIV. "… I'm gonna die" he thought, and "I've been waiting to see if anything would go wrong with me." Another participant reported that he was attempting to quit using IV drugs when he was diagnosed, and thought…"What's the point? I'm either going to die from drugs or from liver disease." He noted that immediately after his diagnosis he began using drugs again. Conversely, one participant reported feeling relief at the diagnosis. He said: "On a scale from 1-10, probably 9 on relief.…. [T] here is a reason why I feel so @#!%*!." While some participants reported being surprised or shocked when first diagnosed, others were not surprised at all, usually because of their pattern of IV drug use.
Theme 2 -Method of Contracting HCV
When participants were asked if they knew how they contracted HCV, some assumed that their IV drug use was to blame, while others sought alternative explanations and insisted they always used clean needles. One participant said "Either, by doing IV drugs or being a lifetime long-term nursing aide…. Other than that, I have no idea. I never shared needles with anybody." Similarly, "I used intravenous drugs, but they were always clean. I would use them fresh out of the package."
Another explanation for contracting HCV was through immunization guns used during the Vietnam War. Three different participants claimed that large numbers of soldiers were immunized in succession without needle sterilization. One participant said, "[B]ecause of the (immunization) guns they used back when they were shooting us. You know for a bunch of shots and stuff,…. I don't use intravenous drugs. I did, but that was probably 30 years ago.… [T]hat was just for a short period of time…that or tattoos….
[T]here's sex."
Another said, "I might've gotten it through those air injectors? The military used those air guns." In summary, participants acknowledged that their behavior likely contributed to contracting HCV, while others reviewed all possible causes for acquiring HCV and focused on their efforts to use clean needles. That's sort of a depressing situation. You're trying to be honest with yourself." Another participant reported that his marriage has been significantly affected. "… a bunch of arguments over the hepatitis C thing. She swears I got it from screwing around with some girl.…I haven't had sex with my wife since she found out I had HCV."
Of interest, participants with families experienced them as being supportive. One said: "I don't believe it has (harmed his relationships)…. My brother has it, my step brother, he has it, my best friend has it.…[T]hey are very supportive. They know all about the interferon that I went through, …that it's incurable…." Another participant suggested it had brought him closer to his family: "[E]ven the kids showed increased concern…. Asking me what's going on and asking me what's going on with the doctors. And I've got friends that really developed strong presence you know, it's kind of neat, I like it."
Theme 5 -Substance Use Disorders and Chronic HCV
Participants were asked about a history of alcohol and IV drug use and they were asked about how they contracted HCV. A separate theme that emerged was the connection between motivation for recovery from substance use disorders and motivation to seek medical treatment for chronic HCV infection. Some participants reported that they ignored their hepatitis C status until they became clean and sober, and only then were they able to actively get medical care or do anything about their hepatitis C. "When I first I got diagnosed with it…, I didn't want to take the hepatitis C treatment cause I didn't think it was all that bad…. Then when I got sober, … for a couple of years, then I decided to do something." Another said,"[I]t wasn't until …I was getting sober…. that I found something I could do about it". Others reported that getting diagnosed with hepatitis C gave them motivation to either initiate or stay active in substance abuse recovery. "[I]t's an added reason to stay sober.…a good excuse not to drink, I can't party with ya anymore." Another said," [F] inding out about that (HCV) was what really regimented me… into the program by staying clean and sober. I go back to the drugs and just turn back on the treatment and everything that has to do with HCV. I mean I'd die a lot quicker…."
Theme 6 -Psychiatric and Medical Co-Morbidity
Many participants reported past psychological problems. Participants viewed psychological issues as being very important when considering treatment options. The following excerpts show the concern two participants had about getting treatment. "I was in Vietnam, my PTSD has gotten me way out in left field. And I've talked to people who's taking that same treatment (Interferon and ribavirin). It's f**ed them up… really bad." Another said…"they were going to give the interferon 2 months before I got it, but I was so anxious about taking it… I was having problems with my PTSD and taking Prozac, Dr…., she recommended me to see the psychiatrist."
Other medical co-morbidities made disease self-management and treatment decisions more complex for both participants and health care providers. Participants listed a variety of conditions when asked about what other medical problems they faced. Comments included the following"I'm not going for … back surgery for …, a herniated disk. And I won't take spinal taps either... I've had my leg worked on, I broke my ankle, they put a plate in there. I got my jaw broke and I got a plate up here." Others said the following:"I got degenerate arthritis, I have emphysema…"; "Probably heart disease and um, …, emphysema"; "Congestive heart failure, I have severe arthritis on my left knee, due to injury."
Theme 7 -Antiviral Treatments
Of the 22 participants, eight reported having been treated with antiviral medications. Despite hearing "horror stories" about antiviral treatment, three participants reported that treatment was not as bad as expected. "About the worst thing I've experienced was some nausea… but it's not near of what they said. Even the tape that they show you when you go to the educational class, … its not near as (bad as that)…." Four of eight participants reported milder symptoms, while another two reported moderate symptoms such as "a lot of fatigue after taking my shot" but found treatment tolerable. Finally, two participants reported that their side effects were severe enough to stop treatment. One participant with a history of depression described his treatment experience as follows: "The first week …it was ok. … Second week was flu like symptoms, feeling hot all the time. I couldn't sleep. …then it accelerated and the third week… I was up and down, irritable, pissed off, then I would be crying and then I'd be happy. … the fourth week is when I was late for work … I felt bad, I wanted to kill, I just wanted to kill somebody. Too much stress. …I informed my supervisor … that I was on (interferon). I saw the psychologist, … and that's when I volunteered to go to a psychiatric ward."
Theme 8 -Self-Management
Almost all participants expressed a desire to learn more about how they could prevent further liver damage and prevent transmission to others. "I have to make sure that if I cut myself… no blood will transfer. … I diet, I try not to a eat a lot of fatty type of meals. My family's from the South…."; "I've quit drinking, I've quit smoking, I've quit drugging.. I was 297 lbs and I'm down to 262…because I was told that it'll help my liver."; "… before HCV, I was like… let the medical community take care of it…. I really didn't do my part….
[S]ince I've found out about HCV and became set in my mind,… it's like I set up a habit."
DISCUSSION
The interviews we conducted with HCV-infected veterans produced important data that was used in the development of a HCV self-management program and may help clinicians better understand the problems and needs of people with HCV. Previous qualitative studies of HCV-infected individuals have not included veterans and have tended to focus on specific subtopics. Although our data are limited to a small convenience sample of HCV-infected US veterans and results are not readily generalizable, our broad focus on all aspects of living with HCV, and lack of restriction on participant responses produced interesting and novel results. We note also that the characteristics of our sample were similar to those of a broader sample of 129 consecutive patients from the VA San Diego HCV clinic 41 and another large study of VA patients with HCV
42
. That sample was 97% male, 77% white, 48% previously married (divorced/widowed), 69% with alcohol disorder, and a median age of about 50 years.
Despite previous studies of HCV-infected persons which concluded that knowledge about the risks of IV drug use was fairly good 32, 33 , our results suggest that participants still have misconceptions about HCV. Recent efforts by the VA National HCV Program address this need 43 , but more education appears needed. Participant conceptions about "using clean needles," transmission of the virus, the benefit of lifestyle changes, and antiviral treatment can also be addressed through a recently developed self-management program that provides interactive skills training in addition to basic information on HCV. Social/relationship issues emerged as an important and common theme. Patients reported difficulty with a variety of encounter types including dating, telling people about their HCV, family interactions, and long-term/marital relationships. This is consistent with previous data suggesting that relationships are strained by worries about future health and fear of infection transmission and that such concerns may lead to reduced social interaction 28 . To address this need, the HCV self-management program includes modules on improving both general and patient/physician communication skills. Participants who reported positive experiences, such as families being brought together and participants getting helpful social support, can serve as peer models for others with difficulty.
VA patients have higher rates of substance use disorders and higher rates of hepatitis C than the general US population 4, 44 . Not surprisingly, high rates of past IV-drug use (73%) were reported ( Table 1) . The most interesting finding that emerged from the data was the psychological or motivational connection between IV-drug use. Some participants only became willing or motivated to get treatment for their substance use disorders once they knew they had HCV, and conversely, others reported that they were unable or unwilling to do anything about their HCV infection until they became abstinent from substances. This information could have important implications for clinical care and intervention development and has not been described in prior studies with IV drug users 34, 35 . Programs may be more effective if they address both substance use and HCV at the same time. Substance use is addressed on multiple occasions in the HCV self-management program through educational sessions, and in a separate module from a harm reduction perspective. Similar to previous qualitative studies on antiviral treatment for HCV 36, 37 , some patients reported experiencing serious side effects and intense emotions, but others reported that treatment was very tolerable and listed strategies for getting through them. Some participants obtained information about antiviral treatment from potentially unreliable sources and expressed fear about treatment. Worry was alleviated by obtaining reliable information, and treatment was often less stressful than participants had feared. To address this need, we created a self-management treatment discussion section, where HCV healthcare professionals and peers who have undergone treatment talk about their experience and answer questions for self-management participants.
Similar to previous studies 10, 26, 34 , we found that most participants reported a variety of negative feelings when first diagnosed with HCV. Interestingly, we found that reactions to being diagnosed with HCV tended to be less intense or even relief when IV-drug use was present. Regardless of participants' initial reaction, their responses indicated that obtaining reliable information, support, and access to resources from a healthcare professional right away was important. VA patients typically obtain health information and supportive care through their local primary care or hepatitis C clinic but many eligible patients do not seek services. Information and education about HCV are also currently available to VA patients nationwide through a patient Website 43 . Consistent with prior studies, 26, 27, 30 health-related quality of life was impacted in a number of ways including physical symptoms, psychological symptoms, and impaired occupational functioning 45 . The experience of fatigue was common, but it was often unclear how much of the fatigue was due to HCV versus normal aging or lifestyle (substance use, diet, depression). Previous studies debate whether psychological and cognitive symptoms related to HCV-infection can be attributed to the biological disease process or mainly result from the stress of living with a serious chronic illness 46, 47 .
Regardless, psychological symptoms were prevalent in our sample and in previous studies, and therefore deserve attention. Some participants' locus of control in explaining their infection was external while others internalized this attribution. It is unclear whether accepting responsibility for becoming infected is helpful or harmful. Physical and psychological symptoms are addressed in the HCV self-management program using many different modules including "dealing with difficult emotions," depression management, fatigue management, relaxation techniques, pain management, and self-talk. Our study has a number of limitations that should be acknowledged. A small convenience sample was used, so it is difficult to generalize to broader groups. However, the characteristics of our sample are similar to those of other studies of VA patients with HCV 4, 42 . Another limitation was that the interviews were conducted by researchers with clinical health assessment training. Prior experience with more structured approaches may have limited or influenced the qualitative data that were collected.
The interviews produced rich qualitative data on the impact that HCV had on the lives of 22 VA patients. Similar to previous studies, we found that the initial HCV diagnosis was difficult and impactful, that interpersonal relationships and quality of life were affected throughout the HCV experience, and that side effects of antiviral treatment were often significant. Unlike some previous studies, some participants were lacking basic HCV health information. Finally, our study produced novel data about locus of control in contracting HCV, and about how the connection between substance use and HCV may influence patient motivation for treatment and recovery.
The qualitative interviews added the patient perspective to the development of an HCV self-management program that is currently being tested with results forthcoming. Future research should continue to explore the connections between substance use, mental health, and HCV infection, and find ways to address them simultaneously instead of individually. Because antiviral treatment is not successful for most HCVinfected individuals, more research should address the reduced quality of life that these people experience.
